肺癌血肿瘤标志物的研究进展  

Research Progress of Blood Tumor Marker of Lung Cancer

作　　者：严会志[1] 张军[1] 

机构地区：[1]湖北医药学院附属太和医院胸心外科,湖北十堰442000

出　　处：《医学综述》2013年第23期4274-4276,共3页Medical Recapitulate

摘　　要：肺癌是严重危害人类健康的疾病,其发病率和病死率位居全球恶性肿瘤的首位,长期以来肺癌的预后一直较差,主要是因为得不到及时的诊断和治疗。从2008年起肺癌早期诊断方法的研究,特别是肺癌血肿瘤标志物一直是科研工作者研究的热点。该文主要就最新的肺癌血肿瘤标志物包括胃泌素释放肽前体片段、循环DNA、微小RNA和表面增强激光解析电离飞行时间质谱进行综述。Lung cancer is a disease which threatens the public health seriously, both its incidence and fatality rate arc the highest among all cancers worldwide, and the persistent dismal prognosis is mainly attribu- ted to late diagnosis and treatment. The discovery of early diagnostic methods has been focused on, especially on the study of blood tumor markers for lung cancer since 2008. Here is to make a review of the latest blood tumor markers of lung cancer include pro-GRP, circulating DNA, mieroRNA and surface enhanced laser desabsorbtion ionization time of flight mass spectrometry.

关 键 词：肺癌 血肿瘤标志物 早期诊断 

分 类 号：R655.3[医药卫生—外科学]